Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: Pyrotinib
Sponsor: RenJi Hospital